Bassem I. Zaki

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kerrington D. Smith · 4 shared papers, 2012–2024 · strength 0.32
   • Paper Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer: A Single-Center… DOI 10.1097/coc.0000000000001052↗
   • Paper Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic ad… DOI 10.1016/j.gie.2016.02.047↗
   • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
2. G.S. Gill · 1 shared paper, 2024 · strength 0.28
   • Paper Initial Observation of Contrast Profiles for 2-Dimensional and 3-Dimensional Magnetic Resonance Imaging Sequences in Ma… DOI 10.1016/j.adro.2023.101314↗
3. Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
4. Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
5. John Ng · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
6. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
7. Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
8. Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
9. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
   • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
   • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
10. Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
11. Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
12. Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
13. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
14. Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
15. Parag Jitendra Parikh · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
16. Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
17. Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
    • Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
    • Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
18. Gabriel A. Brooks · 1 shared paper, 2024 · strength 0.21
    • Paper Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer: A Single-Center… DOI 10.1097/coc.0000000000001052↗
19. Minerva Nong · 1 shared paper, 2024 · strength 0.21
    • Paper Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer: A Single-Center… DOI 10.1097/coc.0000000000001052↗
20. Stuart R. Gordon · 4 shared papers, 2012–2016 · strength 0.15
    • Paper Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic ad… DOI 10.1016/j.gie.2016.02.047↗
    • Paper Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant thera… PMID 24147160↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
21. Richard J. Barth · 3 shared papers, 2012–2016 · strength 0.11
    • Paper Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic ad… DOI 10.1016/j.gie.2016.02.047↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
    • Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
22. Timothy B. Gardner · 3 shared papers, 2012–2016 · strength 0.11
    • Paper Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic ad… DOI 10.1016/j.gie.2016.02.047↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
    • Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
23. Gregory J. Tsongalis · 3 shared papers, 2012–2014 · strength 0.10
    • Paper Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant thera… PMID 24147160↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
    • Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
24. Arief Antonius Suriawinata · 3 shared papers, 2012–2014 · strength 0.10
    • Paper Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant thera… PMID 24147160↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
    • Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
25. J. Marc Pipas · 3 shared papers, 2012–2014 · strength 0.10
    • Paper Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant thera… PMID 24147160↗
    • Paper The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. DOI 10.1097/mpa.0000000000000162↗
    • Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.